NEW YORK (GenomeWeb News) – DNA Genotek said today that Prometheus will use its sample-collection kits for a saliva-based genetic test for celiac disease.
Under the agreement, Prometheus will use DNA Genotek's Oragene DNA kit, a non-invasive DNA self-collection method, to collect saliva samples for the MyCeliacID test.
The DNA-based test is designed to detect variations in the DQ gene that are specific to celiac disease in order to estimate individual risk.
Celiac disease affects around 3 million Americans, the company said, but only around 100,000 cases are diagnosed.
The MyCeliacID test is currently available in most parts of the US, Canada, and Mexico, the company said. Patients order the test online and send the sample to Prometheus' CLIA lab for analysis. Test results are available online via a secure link.